Thursday, May 30, 2019

Expert panel to examine 324 FDC drugs categorised #39;irrational#39;

Expert panel to examine 324 FDC drugs categorised #39;irrational#39; Sale of the 324 FDCs under review may not be more than Rs 500 crore, as most drug companies stopped production after anticipating the ban.

from Moneycontrol Business News http://bit.ly/2Mjg3un

No comments:

Post a Comment

IREDA shares rise 1.1% as board announces meeting date for fund raise via QIP

IREDA shares rose by 1.1% to Rs 209.50 on news of a board meeting set for January 23, 2025, to approve fund-raising via Qualified Institutio...